021-51111890
购物车（）
sales@molnova.cn
SR11237
CAS No. 146670-40-8
SR11237 ( BMS-649 )
产品货号. M27716 CAS No. 146670-40-8
SR11237 是一种泛视黄醇 X 受体 (RXR) 激动剂。 SR11237 导致 RXR/RXR 同二聚体形成并反式激活含有 RXR 响应元件的报告基因。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥1492 | 有现货 |
|
| 10MG | ￥2261 | 有现货 |
|
| 25MG | ￥3692 | 有现货 |
|
| 50MG | ￥5357 | 有现货 |
|
| 100MG | ￥7119 | 有现货 |
|
| 500MG | ￥14310 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ￥1577 | 有现货 |
|
生物学信息
-
产品名称SR11237
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述SR11237 是一种泛视黄醇 X 受体 (RXR) 激动剂。 SR11237 导致 RXR/RXR 同二聚体形成并反式激活含有 RXR 响应元件的报告基因。
-
产品描述SR11237 is a Pan retinoid X receptor (RXR) agonist. SR11237 causes RXR/RXR homodimers to form and transactivate a reporter gene containing a RXR-response element.(In Vitro):SR11237 is effective at transactivating a chloramphenicol acetyltransferase reporter gene through RXRs but not retinoic acid receptors in COS-1 cells.(In Vivo):In Sprague-Dawley rats, SR11237 (BMS-649) (25 mg/kg; i.p.) Caused disturbed ossification and bone morphology in rats, including premature growth plate closure and infiltration of ossified tissue through the central epiphysis.
-
体外实验Using nuclear receptor co-transfection assays in COS-1 cells, that SR11237 is effective at transactivating a chloramphenicol acetyltransferase reporter gene through RXRs but not retinoic acid receptors.
-
体内实验SR11237 (BMS-649) (25 mg/kg; i.p.; daily from post-natal days 5 to 15) causes irregular ossification and premature closure of the growth plate. Animal Model:Sprague-Dawley rats Dosage:25 mg/kg Administration:I.p.; daily from post-natal days 5 to 15 Result:Caused disturbed ossification and bone morphology in rats, including premature growth plate closure and infiltration of ossified tissue through the central epiphysis.
-
同义词BMS-649
-
通路Others
-
靶点Other Targets
-
受体Aurora A
-
研究领域——
-
适应症——
化学信息
-
CAS Number146670-40-8
-
分子量380.484
-
分子式C24H28O4
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 5 mg/mL (13.14 mM)
-
SMILESCC1(C)CCC(C)(C)c2cc(ccc12)C1(OCCO1)c1ccc(cc1)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Ando R, et al. 3-Cyano-6-(5-methyl-3-pyrazoloamino)pyridines: selective Aurora A kinase inhibitors. Bioorg Med Chem Lett. 2010;20(15):4709-4711.
产品手册
关联产品
-
NCGC00135472
NCGC00135472 (DRV1 (GPR32) agonist C2A) is a human Resolvin DI receptor DRV1 agonist with pro-catabolic properties that activates the human soluble protein D1 receptor DRV1/GPR32 receptor in beta-blocker and cAMP assays with EC50s of 0.37 uM and 0.05 uM, respectively.NCGC00135472 induces in cells overexpressing recombinant DRV1 rapid impedance changes that stimulate phagocytosis of serum-treated zymoglycans.
-
Pam3CSK4-Biotin
Pam3CSK4-Biotin is biotinylated Pam3CSK4. Pam3CSK4-Biotin is a Toll-like receptor 1/2 (TLR1/2) agonist.
-
3-O-β-D-xylopyranosy...
3-O-β-D-xylopyranosyl-(1→3)-β-D-glucuronopyranosyl-medicagenic acid 28-O-β-D-xylcopyranosyl-(1→4)-a-L-rhamnopyranosyl-(1 →2)-β-D-fucopyranosyl ester
